- Updated Oct. 28, 2022 with “heavy menstrual bleeding”
- Updated Oct. 9, 2022 with organ and corneal transplant failures
- Updated Oct. 8, 2022 with Florida Surgeon General recommending against for men under 40 due to risk of death from heart problems
- Updated Oct. 1, 2022 with menstrual cycle changes
- Updated Sept. 1, 2022 with higher risks for mRNA vaccines
- Updated Aug. 31, 2022 with hemorrhragic stroke risk re: Pfizer
- Updated Aug. 5, 2022 with heart risk re: Novavax
- Updated June 25, 2022 with higher Covid rate among vaccinated
- Updated June 18, 2022 with Novavax heart concerns
- Updated June 14, 2022 with Bell’s Palsy and Ramsay Hunt Syndrome concerns
- Updated May 11, 2022 with FDA limiting J&J due to blood clot concerns
- Updated April 26, 2022 with more Guillain Barre paralysis concerns
- Updated March 12, 2022 with studies on vaccine-related tinnitis
- Updated Feb. 14, 2022 with pathologist study on heart deaths in children after vaccination
- Updated Jan. 20, 2022 with new warnings about serious neurological and blood conditions
- Updated Jan. 12, 2022 with additional blood disorder warnings
- Updated Jan 13, 2022 with study confirming menstrual cycle changes in women after vaccination
- Updated Jan. 13, 2022 with concerns about repeat boosters
- Updated Dec. 24, 2021 with Danish study again confirming serious heart inflammation risk from vaccination
- Updated Dec. 16, 2021 with CDC warning of dangerous blood clot risk with Johnson & Johnson vaccine
- Updated Dec. 15, 2021 with CDC confirming Johnson and Johnson vaccine link to Guillain Barre paralysis
- Updated Dec. 14, 2021 with British study showing increased heart inflammation risk from vaccination
- Updated Nov. 21, 2021 with “dramatic” increase in risk of heart injury
- Updated Nov. 14, 2021 with Taiwan suspending second dose of Covid vaccine for children
- Updated Nov. 13, 2021 with concerns over Capillary Leak Syndrome
- Updated Nov. 10, 2021 with Germany limiting Moderna in young people; pregnant women
- Updated Nov. 7, 2021 with study showing 2 of 3 U.S. vaccines under 50% effectiveness after 6 mos.
- Updated Oct. 30, 2021 with UK study showing no difference between vaccinated and unvaccinated in peak viral load
- Updated Oct. 29, 2021 with Israel study showing waning immunity in a few months in all age groups after vaccination
- Updated Oct. 23, 2021 with increased rate of preterm birth in pregnant women
- Updated Oct. 10, 2021 with Iceland pausing Moderna over increased heart problems
- Updated Oct. 8, 2021 with Vietnam study about vaccinated people carrying more Delta viral load; spreading Covid
- Updated Oct. 7, 2021 with Finland pausing Moderna vaccine for young males due to heart issues.
- Updated Oct. 6, 2021 with Sweden and Denmark halting Moderna in young people due to risk of heart injuries. Slovenia suspends Johnson & Johnson.
- Updated Oct. 4, 2021 with study about vaccine immunity quickly wearing off
- Updated Oct. 3, 2021 with EU blood disorder concerns and Hepatitis C death
- Updated Sept. 19, 2021 with British study about menstrual cycle changes in women
- Updated Sept. 12, 2021 with study finding teenage boys face much higher heart risk from vaccine than Covid
- Updated Sept. 10, 2021 with Israel study on majority of hospitalized being vaccinated
- Updated Sept. 9, 2021 with CDC study about increased myocarditis/heart inflammation risk, lymphadenopathy, appendicitis, and herpes zoster infection
- Updated Sept. 4, 2021 with acute CNS demyelination after Pfizer and Moderna vaccines
- Updated Aug. 30, 2021 with Functional Neurological Disorder
- Updated Aug. 24, 2021 with waning immunity
- Updated Aug. 17, 2021 with Bell’s Palsy analysis, Hong Kong
- Updated Aug. 16, 2021 with Antibody Dependent Enhancement (ADE) study
- Updated Aug. 5, 2021 with heart disorders more common than CDC reported from database
- Updated July 22, 2021 with EU warning about Guillain-Barre autoimmune paralysis after Johnson and Johnson vaccination.
- Updated July 12, 2021 with new FDA warning of Guillain-Barre autoimmune paralysis cases after vaccination.
- Updated July 12, 2021 with reports of Graves disease autoimmune disorder after vaccination.
- Updated July 1, 2021 with reports of Guillain-Barre paralysis cases after vaccination.
- Updated June 30, 2021 with news of first case of blood clot disorder in double-dose RNA vaccine
If you find yourself confused about the mixed guidance when it comes to Covid-19 vaccines and safety concerns, you’re not alone.
While the Centers for Disease Control (CDC) is marketing widespread use of the vaccines in the U.S. for both old and young alike; many other countries have limited Covid-19 vaccine use under certain conditions. Health officials around the world are giving varying advice on safety issues as Covid-19 vaccines are given to more people, and more information is collected.
Below are summaries of some of the concerns that have emerged or been raised by medical officials.
Click here to jump to: Summary by safety concern
General
Acute CNS Demyelination and Multiple Sclerosis
Antibody Dependent Enhancement (ADE)
Appendicitis
Blood Clots and Blood Disorders
Capillary Leak Syndrome (Clarkson’s disease)
Covid Infection
Frail, Elderly
Functional Neurological Disorder (FND)
Graves Disease Autoimmune Disorder
Heart Issues (also see Blood Clots)
Hepatitis C Reactivation and Death
Herpes Zoster Infection
Lymphadenopathy
Manufacturing Problems
Menstrual Cycle Changes
Paralysis: Guillain-Barre Syndrome, Ramsay Hunt Syndrome, Bell’s Palsy & Other Paralysis
Pregnant Women
Previously Infected
Tinnitis
Transplant Rejection
Click here to jump to: Summary by vaccine
Pfizer, Moderna
Johnson & Johnson
AstraZeneca
Click here to jump to: Summary by country (in alphabetical order)
Click here to jump to: Additional reading and studies
General
Updated Sept. 1, 2022: A study in the journal Vaccine finds: Excess risk of serious adverse events from Pfizer and Moderna Covid-19 vaccines outweighs risks from Covid-19 itself. Pfizer vaccine: 36% higher risk of serious adverse events than placebo. Moderna: 6% higher. Combined: 16% higher.
In the UK, some scientists analyzed adverse event reports and called upon the Medicines and Healthcare Products Regulatory Agency to stop the Covid-19 vaccines as “not safe for human use” due to reports of issues with bleeding/clotting, pain, immune system, neurological, loss of sight/hearing/smell/speech, and questions about impact in pregnant women.
A petition of scientists led by Linda Wastila, Professor, Pharmaceutical Health Services Research University of Maryland School of Pharmacy is calling for Covid-19 vaccines to be disapproved.
Fifty-seven authors from 17 countries have signed an endorsement urging that Covid-19 vaccinations be stopped unless new safety mechanisms are immediately implemented.
The authors include Dr. Peter McCullough, cardiologist and former Vice Chief of Medicine at Baylor University Medical Center in Dallas, Texas, who has called for a halt to vaccinating 30-year olds due to “no clinical benefit” and safety concerns. [McCullough is currently Senior Professor of Internal Medicine at the Texas A&M University Health Sciences Center.]
Acute CNS Demyelination and Multiple Sclerosis
A new study in Journal of Neurology examines possible links between Pfizer and Moderna vaccines, and acute Central Nervous System (CNS) demyelination, including Multiple Sclerosis (MS).
Demyelinating diseases damage the protective covering surrounding nerve fibers in the brain, optic nerves and spinal cord, causing neurological problems. In the study, four patients had the Pfizer vaccine and three had the Moderna vaccine. Within 21 days of the first or second dose, the patients developed active CNS demyelination of the optic nerve, brain, and/or spinal cord leading to “visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance, and limb weakness.”
Age ranged from 24 to 64 years old. Four patients were ultimately diagnoses with exacerbation of their stable MS.
Two were diagnosed with new cases of MS.
One was diagnosed with neuromyelitis optica.
Antibody Dependent Enhancement (ADE)
Updated (read more here). According to studies:
- Antibody Dependent Enhancement (ADE) can make vaccinated people more susceptible to serious infection from the virus
- “ADE may be a concern” for those who have been vaccinated for Covid-19
- With ADE, after people get vaccinated for an initial virus, infection by a subsequent variant or strain of the virus can result in “increased viral replication and more severe disease, leading to major safety risks”
- ADE can also “occur when neutralizing antibodies (which bind the virus and stop it from causing infection) are present at low enough levels that they don’t protect against infection. Instead, they can form immune complexes with viral particles, which in turn leads to worse illness”
- This concern was initially described by some scientists who were subsequently banned from media platforms that incorrectly claimed the scientists were disseminating disinformation
Appendicitis
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with increased risk of appendicitis, according to a real-world case-control study from Israel.
Blood Clots and Blood Disorders
Updated Aug. 31, 2022: A Hong Kong study finds Pfizer vaccine carries increased risk of hemorrhragic stroke after Pfizer vaccine. The study authors say it’s still a benefit to get vaccinated, though, because the stroke rate among Covid patients is even higher. But that wrongly assumes vaccination prevents Covid. It also compares the wrong pools of patients. To look at true risk vs. benefit, the stroke rate should be compared between vaccinated people and all unvaccinated people– not just those with Covid.
Updated May 11, 2022: FDA limits use of Johnson & Johnson vaccine citing risk of thrombosis with thrombocytopenia syndrome (TTS): blood clots in combination with low levels of blood platelets.
Updated Jan. 20, 2022: The FDA has added a warning about immune thrombocytopenia, ITP, to Johnson & Johnson’s vaccine.
Updated Dec. 17, 2021: CDC warns of risk of blood clots, Thrombosis with Thrombocytopenia Syndrome (TTS), with Johnson & Johnson vaccine and recommends people get Moderna or Pfizer, instead.
Updated Oct. 6, 2021: Slovenia has temporarily halted Johnson & Johnson vaccine after a stroke death in a 20 year old woman.
In late June, the first case of a blood clot disorder called “thrombosis with thrombocytopenia” after an RNA double-dose vaccine was been reported in the Annals of Internal Medicine. The case was that of a 65-year-old man who developed symptoms ten days after his second dose of the Moderna vaccine. Because the blood clot disorder was not previously warned about in the Moderna and Pfizer vaccines, doctors treated the patient with heparin, the very drug that’s not supposed to be used in post-vaccine patients suffering from the disorder because it could actually worsen the condition.
The Johnson and Johnson Covid-19 vaccine was temporarily removed from the market in the U.S. on April 16, 2021 while health officials studied reports of blood clot injuries. Among them was an 18-year old teen named Emma Burkey, who got sick about a week after the Johnson and Johnson Covid-19 vaccine and ended up having three brain surgeries related to blood clots and seizures.
Read: BBC radio news anchor dies of blood clots after Covid vaccine
The Johnson and Johnson vaccine was allowed back on the market April 27, 2021 with new warnings about the disorder.
Swedish health officials determined that people under age 65 should not get the Johnson and Johnson vaccine due to reports of blood clots.
An editorial published in the Journal of the American Medical Association recommended women under age 50 avoid the Johnson and Johnson Covid-19 vaccine due to concerns about blood clots. The recommendation discussed 12 case reports of a blood disorder known as cerebral venous sinus thrombosis (CVST) with thrombocytopenia following the Johnson and Johnson vaccine.
The AstraZeneca Covid-19 vaccine (not currently approved in the U.S.) has been linked to a dangerous disorder involving blood clots with low blood platelets. On April 7, 2021, the European Medicines Agency says it made the association after it analyzed 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of March 22, 2021; 18 of which were fatal.
An otherwise healthy South Florida doctor, Gregory Michael, died of a brain hemorrhage 16 days after he got Pfizer’s Covid-19 vaccine. Authorities concluded he died of a blood disorder called “immune thrombocytopenia” (ITP) that can prevent blood from clotting and cause internal bleeding. His wife said a blood test showed the level of his platelets to be at “zero.” She said before the shot, Dr. Michael had “absolutely no medical issues” and no underlying conditions. However, authorities later categorized his death as “natural.”
In Spain, the AstraZeneca shot has been restricted in people under age 60 due to reports of blood clots in younger people.
Bulgaria, Iceland and Norway halted AstraZeneca shots for a time due to blood issues or impact on frail. Iceland, and possibly others, reinstated it in people over age 70 and, perhaps, in some over age 60.
Austria, Italy and Romania banned certain “lots” or batches of the AstraZeneca shots.
Denmark stopped using the AstraZeneca Covid-19 vaccine altogether as well as the Johnson and Johnson vaccine after investigations into blood clots, saying “the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.”
The Italian government recently restricted AstraZeneca Covid-19 vaccine to adults over age 60 after a teenager who got the shot died from a rare form of blood clotting. Eighteen-year-old Camilla Canepa died after getting vaccinated May 25, 2021.
Several other European countries have also stopped giving the AstraZeneca Covid-19 vaccine to people below a certain age, usually ranging from 50 to 65.
Updated Sept. 9, 2021: An August 10 study in JAMA Cardiology urged caution in giving Covid-19 vaccine to certain high risk patients due to the vaccine link to a serious blood disorder: thrombocytopenia with thrombosis. “One of the devastating manifestations of this syndrome, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST),” say the study authors. The link involves the AstraZeneca/Oxford and Johnson & Johnson vaccines, according to the study. The AstraZeneca vaccine is not administered in the U.S. currently.
Read about a case of VITT in an otherwise healthy mother who died after vaccination.
Updated Oct. 3, 2021: The European Medicines Agency recommended that blood clotting in deep veins and immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as adverse reactions to Johnson and Johnson vaccine. The ITP disorder is also linked to the AstraZeneca Covid-19 vaccines, which are not used in the U.S.
Capillary Leak Syndrome (Clarkson’s disease)
Updated Nov. 13, 2021: European Medicines Agency (EMA) announced a review of Moderna vaccine and a possible link to Capillary Leak Syndrome, “a rare disorder involving repeated leaks of large amounts of plasma from blood vessels into nearby body cavities and muscles. The condition—known as Clarkson’s disease—can result in a sharp drop in blood pressure that can lead to organ failure or even death.”
Earlier in the year, the EMA required Capillary Leak Syndrome to be added to the warning label of AstraZeneca’s Covid-19 vaccine (which is not used in the U.S.)
Covid Infection
Nearly every measure finds the Covid infection rate is higher among the vaccinated than among the unvaccinated.
“..the trend line suggests a marginally positive association such that countries with higher percentage of population fully vaccinated have higher COVID-19 cases per 1 million people. Notably, Israel with over 60% of their population fully vaccinated had the highest COVID-19 cases per 1 million people in the last 7 days. The lack of a meaningful association between percentage population fully vaccinated and new COVID-19 cases is further exemplified, for instance, by comparison of Iceland and Portugal. Both countries have over 75% of their population fully vaccinated and have more COVID-19 cases per 1 million people than countries such as Vietnam and South Africa that have around 10% of their population fully vaccinated.
Frail, Elderly
Health officials in Norway sounded the alarm after 23 patients died shortly after getting the Pfizer Covid-19 vaccine. They advise doctors to use caution in administering the shot to “very frail elderly patients.”
After investigating 13 of the deaths, the Norwegian authorities concluded that common side effects from so-called “RNA” vaccines may be too much for a frail elderly person to handle, and may contribute to their death.
“There is a possibility that these common adverse reactions, that are not dangerous in fitter, younger patients and are not unusual with vaccines, may aggravate underlying disease in the elderly,” said Steinar Madsen, medical director of the Norwegian Medicines Agency.
CDC said it is monitoring the impact of the vaccines on already-frail patients such as the chronically ill in nursing homes.
Several clusters of elderly patients in U.S. nursing homes died after Pfizer or Moderna Covid-19 vaccine. In one group, a number of the patients who died tested positive for Covid-19 after vaccination.
Functional Neurological Disorder (FND)
Researchers in the United Kingdom are studying two additional cases of Functional Neurological Disorder (FND) in women in their 30s after receiving Covid-19 vaccines.
FND is a neurological disorder involving malfunctioning of the nervous system and how the brain and body transmit signals. Symptoms can include limb weakness, paralysis, tremor, spasms, problems walking, speech problems, tingling, vision loss, seizures, fatigue, anxiety, chronic pain, memory symptoms, and blackouts.
An analysis of Covid-19 vaccine adverse events showed hundreds of thousands of reports of such symptoms.
In January, videos showing vaccine patients suffering such symptoms were treated by media outlets such as Wired as if they were fake news and “dangerous” misinformation.
In fact, the videos garnered the attention of scientists who investigated and concluded they were early warnings of what happens to some who get Covid-19 vaccines.
The newest cases are outlined in the journal NeuroPsychiatry and include:
- A 38-year old woman who got her first dose of Pfizer’s vaccine and quickly developed weakness around her ear, mouth, left arm and leg. She went to the ER the next day and was diagnosed with Bell’s palsy or a transient ischemic attack. Problems continued months later, including memory issues, and she was diagnosed with FND.
- A 36-year-old woman who got her second dose of Moderna and quickly noticed weakness in right hand and right leg limping. A day later she reported severe leg heaviness, fatigue, movement difficulties. After physical therapy her right-side weakness improved but she awoke weeks later with left-side weakness, tightness and heaviness in neck, difficulties with daily living, rapid muscle fatigue, dragging right foot, and tremor. She was diagnosed with FND.
Graves Disease Autoimmune Disorder
Studies in Mexico and Turkey link the autoimmune thyroid disorder Graves disease to Covid-19 vaccination in numerous female health care workers, including two who were breastfeeding. Pfizer-BioNTech was the vaccine given in Mexico. A Chinese vaccine was given in Turkey. Read more at the link below.
Heart Issues (see also Blood Clots)
Updated Oct. 8, 2022: Florida surgeon general advises young men should avoid Covid vaccines due to 84% increase in the relative incidence of cardiac-related death among males 18-39 within 28 days following mRNA vaccination.
Updated Aug. 5, 2022: The European Medicines Agency (EMA) recommends Novavax’s Covid-19 vaccine carry warnings about heart inflammation: myocarditis and pericarditis.
Updated June 18, 2022: The FDA flagged the non-mRNA shot Novavax for heart issues similar to the mRNA vaccines, shortly before recommending the okay for Novavax in the US.
Updated Feb. 14, 2022: A pathology report on two children who died of heart issues after their second Pfizer Covid-19 vaccine implicates the vaccine as the cause.
Updated Dec. 24, 2021: A Danish study found people at “significantly increased risk” or heart inflammation after Moderna and Pfizer Covid-19 vaccination “primarily driven by an increased risk among individuals aged 12-39 years.”
Updated Dec. 14, 2021: A British study found people at increased risk of heart inflammation from AstraZeneca (not used in U.S.), Pfizer and Moderna Covid-19 vaccines.
Updated Nov. 21, 2021: An analysis presented at the American Heart Association and published in the journal Cardiology warns of a “dramatic” increase in heart risk for most people who got Covid-19 RNA vaccine.
Updated Nov. 14, 2021: Taiwan’s health minister announced temporary suspension of the second dose of Covid-19 vaccine for children due to concerns about myocarditis heart inflammation. Pfizer is the vaccine given in Taiwan.
Updated Nov. 10, 2021: A German advisory panel says the Moderna shot should not be used in people under 30 or pregnant women because it causes more cases of heart inflammation than Pfizer. Moderna’s rate of heart inflammation in young men was nearly triple that reported after Pfizer. Some health authorities have flagged heart issues with both vaccines.
Updated Oct. 10, 2021: Iceland joins Finland, Sweden and Denmark in pausing Moderna due to increased heart issues such as myocarditis and pericarditis. While some of the countries are permitting Moderna in people over age 30, Iceland is not permitting its use at all, currently.
Updated Oct. 7, 2021: Finland joins Sweden and Denmark in pausing use of Moderna in men 30 and under due to heart issues after a Nordic study found that men under the age of 30 were at a higher risk of developing myocarditis, an inflammation of the heart muscle.
Updated Oct. 6, 2021: Sweden and Denmark have halted use of Moderna in people under age 30 due to increased risk of heart injuries such as myocarditis. Slovenia has temporarily halted Johnson & Johnson.
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from Israel. “Vaccination had a strong association with an increased risk of myocarditis as well as increased risks of lymphadenopathy [swelling or inflammation of lymph nodes], appendicitis, and herpes zoster infection.”
The Food and Drug Administration has added a new warning to Pfizer and Moderna Covid-19 vaccines about risk of heart inflammation.
As of June of 2021, CDC said that more than 1,200 cases of heart inflammation (myocarditis or pericarditis) in young people had been reported after Pfizer and Moderna Covid-19 vaccination.
- More than half were after the second dose.
- Most of the injuries are in males under age 30.
Updated Aug. 4: A new, independent study of medical records found the incidences of myocarditis and pericarditis are more than five times more common than CDC reported.
The Israeli Ministry of Health announced it’s monitoring for heart inflammation after Pfizer’s vaccine due to reports of problems.
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines [Pfizer-BioNTech, Moderna] in a number of patients are described in a scientific article:
- Two patients with clinically suspected myocarditis
- One patient with stress cardiomyopathy
- Two patients with pericarditis
According to the research:
- The two patients with clinically suspected myocarditis were otherwise healthy young men who presented with acute substernal chest pressure and/or dyspnea after receiving the second dose of the vaccine and were found to have diffuse ST elevations on electrocardiogram (ECG), elevated cardiac biomarkers and inflammatory markers, and mildly reduced left ventricular (LV) function on echocardiography. Both patients met the modified Lake Louise Criteria for acute myocarditis by cardiac magnetic resonance imaging.
- A case of stress cardiomyopathy occurred in a 60-year-old woman with known coronary artery disease (CAD) and previously normal LV function, who presented with new exertional symptoms, ECG changes, and apical akinesis following the second dose of the vaccine.
- The two patients with pericarditis who presented with chest pain, elevated inflammatory markers, and pericardial effusions after receiving the vaccine.
Updated Sept.9, 2021: An August 10 study in JAMA Cardiology confirms the previously identified Pfizer vaccine’s myocarditis (heart inflammation) risk in young boys.
Updated Sept. 12, 2021: A study of Pfizer and Moderna vaccines finds teenage boys are six times more likely to suffer heart issues from Covid-19 vaccination than from Covid. (However, in both instances, the risk is considered slight.)
Hepatitis C Reactivation and Death
Update Oct. 3, 2021: Scientists in the Netherlands report an elderly woman suffered “reactivation of hepatitis C infection after vaccination with the mRNA-based Pfizer–BioNTech COVID-19 vaccine. This reactivation manifested with jaundice, loss of consciousness, hepatic coma and death” suggesting “a need for critical consideration of individuals with prior HCV infection and considered for COVID-19 vaccination.”
According to the scientists, “It is known for other vaccines that they can cause virus reactivation, especially in immunosuppressed patients and patients undergoing cancer treatment, eg as described for the herpes zoster subunit vaccine.”
Herpes Zoster Infection
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with an increased risk of herpes zoster infection, according to a real-world case-control study from Israel.
Updated Oct. 3, 2021: An original analysis of adverse events I conducted of the federal Vaccine Adverse Event Reporting (VAERS) showed 6,339 herpes-related reports.
Lymphadenopathy
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with an increased risk of lymphadenopathy, swelling or inflammation of lymph nodes according to a real-world case-control study from Israel.
Manufacturing Problems
On June 11, the European Union’s drug regulator announced it will not use batches of the Johnson & Johnson COVID-19 vaccine that were made at a Baltimore, Maryland-based plant around the time that cross-contamination manufacturing problems were reported at the facility.
Anonymous sources claimed that up to 60 million doses of the Johnson and Johnson vaccine had to be thrown out. But the FDA issued a news release saying that two batches from the Baltimore plant were safe to use. The FDA said “several other batches are not suitable for use, but additional batches are still under review.”
Menstrual Cycle Changes
Updated Oct. 28, 2022: The European Medicines agency recommends “heavy menstrual bleeding” be disclosed as side effect of Covid shots Comirnaty and Spikevac.
Updated Oct. 1, 2022: A study further confirms Covid-19 vaccination leads to a small and hopefully temporary change in menstrual cycle length.
Updated Jan. 13, 2022: A study finds vaccination impacts and delays women’s periods.
Updated Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.
Menstrual changes after covid-19 vaccination
Paralysis: Guillain-Barre Syndrome, Ramsay Hunt Syndrome, Bell’s Palsy & Other Paralysis
Update June 14, 2022: Pop star Justin Bieber announces he has Ramsay Hunt Syndrome paralysis. Scientists have found a suspected link between herpes/shingles/chickenpox activation or reactivation after Covid-19 vaccine, leading to facial paralysis, hearing loss, tinnitus and other disorders.
Update April 26, 2022: Rates of Guillain-Barre “continue to be unusually high after Johnson & Johnson shot” according to a new analysis. “The findings confirm data seen in the Vaccine Adverse Event Reporting System (VAERS) that led to the FDA warning about the Johnson & Johnson vaccine in July 2021….A head-to-head comparison showed the Johnson & Johnson vaccine carried a 20% higher risk for Guillain-Barré than the mRNA shots.”
Update Jan. 20, 2022: European advisers recommended adding warnings about transverse myelitis, a serious spinal inflammation neurological disorder that can paralyze, to Johnson & Johnson’s and AstraZeneca’s Covid-19 vaccines.
Update Dec. 15, 2021: A CDC analysis of adverse events reported to the Vaccine Safety Datalink system confirms an increased risk of Guillain-Barre paralysis after Johnson and Johnson Covid-19 vaccination.
Update Oct. 2021: A study finds link between Johnson and Johnson Covid-19 vaccine and Guillain-Barre paralysis.
Update July 22, 2021: The European Union added Guillain-Barré syndrome, an autoimmune paralysis disorder, as a possible side effect from Johnson and Johnson’s Covid-19 vaccine.
Update July 12, 2021: The FDA added warnings about Guillain-Barre autoimmune paralysis, in which the immune system attacks the body’s nerves, after Johnson and Johnson vaccine. According to reports, the cases have primarily been reported about two weeks after vaccination, mostly in men, and “any aged 50 and older.”
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.” In the U.K., scientists flagged “bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine.” A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca’s vaccine. Six were women, all had facial paralysis, “all progressed to quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement.”
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Pregnant Women
Several Brazilian states suspended use of AstraZeneca’s Covid-19 vaccine for pregnant women in May 2021 after a pregnant woman died after getting vaccinated. The decisions follow the recommendation of the country’s National Health Surveillance Agency, which recommended “immediate suspension” of the AstraZeneca Covid-19 vaccine for pregnant women after results of vaccine adverse events monitoring in the country.
CDC says that with limited data on impact of Covid-19 vaccine in pregnant women and on their unborn children, the decision on whether to vaccinate while pregnant is an individual decision to be made between a woman and her physician.
Updated Oct. 23, 2021: A study of AstraZeneca vaccine (not used in the U.S.) finds 30% preterm birth rate for pregnant women vs. 0% in the control group.
Previously-infected
CDC falsely claimed that studies showed Covid-19 vaccines are effective for those who already had Covid-19. In fact, studies showed the opposite.
Tinnitis
Multiple studies as well as the VAERS database document vaccine-associated tinnitis or ringing and/or noise in one or both ears, which can be a result of nerve damage and can be debilitating.
Transplant Rejection
Updated Oct 9, 2022: A study by Japanese researchers in the Journal of Clinical Medicine showed that acute corneal allografts may be rejected by those who have recently received Covid shots. There are other published studies regarding organ transplant rejection after Covid vaccination. Other vaccines, including flu shots, are also believed to cause organ transplant rejection in some, say scientists.
Waning Immunity, Breakthrough Infections
Read: “Pandemic of the Vaccinated”
Update Jan. 13, 2022: European Union regulators warned that “frequent Covid-19 booster shots could adversely affect the immune system and may not be feasible.” The agency said that “Repeat booster doses every four months could eventually weaken the immune system and tire out people.” The concern arises as more data reveals the Covid-19 shots do not provide effective protection against infection and spread of Covid beyond a short period of time.
Update Nov. 7, 2021: A U.S. study finds after 6 mos. Moderna vaccine effectiveness drops to 60%. Pfizer drops to 49%. J&J drops to 13%. Last yr, FDA’s Dr. Hahn said FDA wouldn’t authorize vaccines that weren’t at least 50% effective.
Update Oct. 30, 2021: A UK study finds “Household Secondary Attack Rate for delta infection, regardless of vaccination status, was 26%” and “peak viral load did not differ by vaccination status.”
Update Oct. 29, 2021: Unlike natural immunity, Israeli data confirms that the Pfizer vaccine wore off in just a few months in all age groups.
Update Oct. 13, 2021: Data from the UK finds vaccines are “highly effective,” but effectiveness wanes after as little as 3-4 months.
Update Oct. 8, 2021: A study of health care workers in Vietnam found vaccinated people infected with Delta Covid-19 carry “unusually high viral loads” in their nostrils that are “251 times higher.” The study said that during a period when the vaccinated patients are infected but don’t yet know it, they could be responsible for heightened spread to other vaccinated or the unvaccinated. The subjects had been fully vaccinated with AstraZeneca’s vaccine, which is not used in the U.S.
Israel announced that about half of the adults infected with Covid-19 during its outbreak in the June 2021 time period were fully vaccinated. The fully-vaccinated individuals had gotten Pfizer’s shots.
According to Epoch Times, in June 2021 nearly 4,000 fully vaccinated people in Massachusetts tested positive for Covid-19. On April 30, “the CDC reported that some 10,626 breakthrough cases were reported in 46 states and territories.” Breakthrough cases are where fully vaccinated people still end up infected with Covid-19.
Scientists hoped that Covid-19 vaccines would be effective in variants of Covid-19, which are mutations that occur naturally with viruses and were always expected with Covid-19. However, the vaccine effectiveness against variants may be limited. CDC and vaccine makers are studying the medical landscape to find out more.
Other states, such as Maine, are noting Covid-19 deaths occurring in fully vaccinated people.
Update Aug. 24, 2021: With evidence of seriously-waning immunity at the five- to six-month mark, CDC is now recommending a third “booster” shot. In highly-vaccinated Israel, recognition that vaccination likely does not confer protection beyond a few months, the country has reimagined its vaccine passports. They will only apply to people who have had three shots, and only be good for a six month period of time.
Update Sept. 10, 2021: An analysis of data in Israel, which has one of the world’s highest Covid-19 vaccination levels, showed almost 60% of those hospitalized for Covid were fully vaccinated. “This is a very clear warning sign for the rest of the world,” said Ran Balicer, CIO at Clalit Health Services, Israel’s largest health maintenance organization. “If it can happen here, it can probably happen anywhere.” The Pfizer vaccine is given in Israel.
Update Oct. 4, 2021: A study by university and NIH scientists in the U.S. finds Pfizer vaccine antibodies disappear after about 7 months in many patients.
Novavax
Updated Aug. 5, 2022: The European Medicines Agency (EMA) recommends Novavax’s Covid-19 vaccine carry warnings about heart inflammation: myocarditis and pericarditis. The FDA flagged heart side effects o Novavax in June of 2022.
Pfizer and Moderna
Updated Sept. 1, 2022: A study in the journal Vaccine finds: Excess risk of serious adverse events from Pfizer and Moderna Covid-19 vaccines outweighs risks from Covid-19 itself. Pfizer vaccine: 36% higher risk of serious adverse events than placebo. Moderna: 6% higher. Combined: 16% higher.
Transplant Rejection
Updated Oct. 9, 2022: A study by Japanese researchers published in June 2022 in the Journal of Clinical Medicine showed that acute corneal allografts may be rejected by those who have recently received Covid shots. There are other published studies regarding organ transplant rejection after Covid vaccination. Other vaccines, including flu shots, are also believed to cause organ transplant rejection in some, say scientists.
Menstrual Cycle Changes
Updated Oct. 1, 2022: A study further confirms Covid-19 vaccination leads to a small and hopefully temporary change in menstrual cycle length.
Updated Jan. 13, 2022: A study finds vaccination impacts and delays women’s periods.
Updated Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.
Menstrual changes after covid-19 vaccination
Acute CNS Demyelination and Multiple Sclerosis
A new study in Journal of Neurology examines possible links between Pfizer and Moderna vaccines, and acute Central Nervous System (CNS) demyelination, including Multiple Sclerosis (MS).
Demyelinating diseases damage the protective covering surrounding nerve fibers in the brain, optic nerves and spinal cord, causing neurological problems. In the study, four patients had the Pfizer vaccine and three had the Moderna vaccine. Within 21 days of the first or second dose, the patients developed active CNS demyelination of the optic nerve, brain, and/or spinal cord leading to “visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance, and limb weakness.”
Age ranged from 24 to 64 years old. Four patients were ultimately diagnoses with exacerbation of their stable MS.
Two were diagnosed with new cases of MS.
One was diagnosed with neuromyelitis optica.
Capillary Leak Syndrome:
Updated Nov. 13, 2021: European Medicines Agency (EMA) announced a review of Moderna vaccine and a possible link to Capillary Leak Syndrome, “a rare disorder involving repeated leaks of large amounts of plasma from blood vessels into nearby body cavities and muscles. The condition—known as Clarkson’s disease—can result in a sharp drop in blood pressure that can lead to organ failure or even death.”
Waning Immunity, Breakthrough Infections
Update Nov. 7, 2021: A U.S. study finds after 6 mos. Moderna vaccine effectiveness drops to 60%. Pfizer drops to 49%. J&J drops to 13%. Last yr, FDA’s Dr. Hahn said FDA wouldn’t authorize vaccines that weren’t at least 50% effective.
Update Oct. 30, 2021: A UK study finds “Household Secondary Attack Rate for delta infection, regardless of vaccination status, was 26%” and “peak viral load did not differ by vaccination status.”
Update Oct. 29, 2021: Unlike natural immunity, Israeli data confirms that the Pfizer vaccine wore off in just a few months in all age groups.
Update Oct. 13, 2021: Data from the UK finds vaccines are “highly effective,” but effectiveness wanes after as little as 3-4 months.
Update Oct. 4, 2021: A study by university and NIH scientists in the U.S. finds Pfizer vaccine antibodies disappear after about 7 months in many patients.
Update Aug. 24, 2021: With evidence of seriously-waning immunity at the five- to six-month mark, CDC is now recommending a third “booster” shot. In highly-vaccinated Israel, recognition that vaccination likely does not confer protection beyond a few months, the country has reimagined its vaccine passports. They will only apply to people who have had three shots, and only be good for a six month period of time.
Update Sept. 10, 2021: An analysis of data in Israel, which has one of the world’s highest Covid-19 vaccination levels, showed almost 60% of those hospitalized for Covid were fully vaccinated. “This is a very clear warning sign for the rest of the world,” said Ran Balicer, CIO at Clalit Health Services, Israel’s largest health maintenance organization. “If it can happen here, it can probably happen anywhere.” The Pfizer vaccine is given in Israel.
Functional Neurological Disorder (FND)
Updated Aug. 30, 2021: Researchers in the United Kingdom are studying two additional cases of Functional Neurological Disorder (FND) in women in their 30s after receiving Covid-19 vaccines.
FND is a neurological disorder involving malfunctioning of the nervous system and how the brain and body transmit signals. Symptoms can include limb weakness, paralysis, tremor, spasms, problems walking, speech problems, tingling, vision loss, seizures, fatigue, anxiety, chronic pain, memory symptoms, and blackouts.
An analysis of Covid-19 vaccine adverse events showed hundreds of thousands of reports of such symptoms.
In January, videos showing vaccine patients suffering such symptoms were treated by media outlets such as Wired as if they were fake news and “dangerous” misinformation.
In fact, the videos garnered the attention of scientists who investigated and concluded they were early warnings of what happens to some who get Covid-19 vaccines.
The newest cases are outlined in the journal Neurology and include:
- A 38-year old woman who got her first dose of Pfizer’s vaccine and quickly developed weakness around her ear, mouth, left arm and leg. She went to the ER the next day and was diagnosed with Bell’s palsy or a transient ischemic attack. Problems continued months later, including memory issues, and she was diagnosed with FND.
- A 36-year-old woman who got her second dose of Moderna and quickly noticed weakness in right hand and right leg limping. A day later she reported severe leg heaviness, fatigue, movement difficulties. After physical therapy her right-side weakness improved but she awoke weeks later with left-side weakness, tightness and heaviness in neck, difficulties with daily living, rapid muscle fatigue, dragging right foot, and tremor. She was diagnosed with FND.
Antibody Dependent Enhancement (ADE)
Updated (read more here). According to studies:
- Antibody Dependent Enhancement (ADE) can make vaccinated people more susceptible to serious infection from the virus
- “ADE may be a concern” for those who have been vaccinated for Covid-19
- With ADE, after people get vaccinated for an initial virus, infection by a subsequent variant or strain of the virus can result in “increased viral replication and more severe disease, leading to major safety risks”
- ADE can also “occur when neutralizing antibodies (which bind the virus and stop it from causing infection) are present at low enough levels that they don’t protect against infection. Instead, they can form immune complexes with viral particles, which in turn leads to worse illness”
- This concern was initially described by some scientists who were subsequently banned from media platforms that incorrectly claimed the scientists were disseminating disinformation
Guillain-Barre autoimmune paralysis and Ramsay Hunt syndrome
Update June 14, 2022: Pop star Justin Bieber announces he has Ramsay Hunt Syndrome paralysis. Scientists have found a suspected link between herpes/shingles/chickenpox activation or reactivation after Covid-19 vaccine, leading to facial paralysis, hearing loss, tinnitus and other disorders.
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.” In the U.K., scientists flagged “bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine.” A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca’s vaccine. Six were women, all had facial paralysis, “all progressed to quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement.”
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Blood Clots
Updated Aug. 31, 2022: A Hong Kong study finds Pfizer vaccine carries increased risk of hemorrhragic stroke after Pfizer vaccine. The study authors say it’s still a benefit to get vaccinated, though, because the stroke rate among Covid patients is even higher. But that wrongly assumes vaccination prevents Covid. It also compares the wrong pools of patients. To look at true risk vs. benefit, the stroke rate should be compared between vaccinated people and all unvaccinated people– not just those with Covid.
The first case of a blood clot disorder called “thrombosis with thrombocytopenia” after an RNA double-dose vaccine was been reported in the Annals of Internal Medicine. The case was that of a 65-year-old man who developed symptoms ten days after his second dose of the Moderna vaccine. Because the blood clot disorder was not previously warned about in the Moderna and Pfizer vaccines, doctors treated the patient with heparin, the very drug that’s not supposed to be used in post-vaccine patients suffering from the disorder because it could actually worsen the condition.
Heart inflammation
Updated Oct. 8, 2022: Florida surgeon general advises young men should avoid Covid vaccines due to 84% increase in the relative incidence of cardiac-related death among males 18-39within 28 days following mRNA vaccination.
Updated Feb. 14, 2022: A pathology report on two children who died of heart issues after their second Pfizer Covid-19 vaccine implicates the vaccine as the cause.
Updated Dec. 24, 2021: A Danish study found people at “significantly increased risk” or heart inflammation after Moderna and Pfizer Covid-19 vaccination “primarily driven by an increased risk among individuals aged 12-39 years.”
Updated Dec. 14, 2021: A British study study found people at increased risk of heart inflammation from AstraZeneca (not used in U.S.), Pfizer and Moderna Covid-19 vaccines.
Updated Nov. 21, 2021: An analysis presented at the American Heart Association and published in the journal Cardiology warns of a “dramatic” increase in heart risk for most people who got Covid-19 RNA vaccine.
Updated Nov. 14, 2021: Taiwan’s health minister announced temporary suspension of the second dose of Covid-19 vaccine for children due to concerns about myocarditis heart inflammation. Pfizer is the vaccine given in Taiwan.
Updated Nov. 10, 2021: A German advisory panel says the Moderna shot should not be used in people under 30 or pregnant women because it causes more cases of heart inflammation than Pfizer. Moderna’s rate of heart inflammation in young men was nearly triple that reported after Pfizer. Some health authorities have flagged heart issues with both vaccines.
Updated Oct. 10, 2021: Iceland joins Finland, Sweden and Denmark in pausing Moderna due to increased heart issues such as myocarditis and pericarditis. While some of the countries are permitting Moderns in people over age 30, Iceland is not permitting its use at all, currently.
Updated Oct. 7, 2021: Finland joins Sweden and Denmark in pausing use of Moderna in men 30 and under due to heart issues after a Nordic study found that men under the age of 30 were at a higher risk of developing myocarditis, an inflammation of the heart muscle.
Updated Oct. 6, 2021: Sweden and Denmark have halted use of Moderna in people under age 30 due to increased risk of heart injuries such as myocarditis.
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from Israel. “Vaccination had a strong association with an increased risk of myocarditis as well as increased risks of lymphadenopathy [swelling or inflammation of lymph nodes], appendicitis, and herpes zoster infection.”
The Food and Drug Administration has added a new warning to Pfizer and Moderna Covid-19 vaccines about risk of heart inflammation.
As of June of 2021, CDC said that more than 1,200 cases of heart inflammation (myocarditis of pericarditis) in young people had been reported after Pfizer and Moderna Covid-19 vaccination.
- More than half were after the second dose.
- Most of the injuries are in males under age 30.
Updated Aug. 4: A new, independent study of medical records found the incidences of myocarditis and pericarditis are more than five times more common than CDC reported.
The Israeli Ministry of Health announced it’s monitoring for heart inflammation after Pfizer’s vaccine due to reports of problems.
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines [Pfizer-BioNTech, Moderna] in a number of patients are described in a scientific article:
- Two patients with clinically suspected myocarditis
- One patient with stress cardiomyopathy
- Two patients with pericarditis
According to the research:
- The two patients with clinically suspected myocarditis were otherwise healthy young men who presented with acute substernal chest pressure and/or dyspnea after receiving the second dose of the vaccine and were found to have diffuse ST elevations on electrocardiogram (ECG), elevated cardiac biomarkers and inflammatory markers, and mildly reduced left ventricular (LV) function on echocardiography. Both patients met the modified Lake Louise Criteria for acute myocarditis by cardiac magnetic resonance imaging.
- A case of stress cardiomyopathy occurred in a 60-year-old woman with known coronary artery disease (CAD) and previously normal LV function, who presented with new exertional symptoms, ECG changes, and apical akinesis following the second dose of the vaccine.
- The two patients with pericarditis who presented with chest pain, elevated inflammatory markers, and pericardial effusions after receiving the vaccine.
An otherwise healthy South Florida doctor, Gregory Michael, died of a brain hemorrhage 16 days after he got Pfizer’s Covid-19 vaccine. Authorities concluded he died of a blood disorder called “immune thrombocytopenia” (ITP) that can prevent blood from clotting and cause internal bleeding. His wife said a blood test showed the level of his platelets to be at “zero.” She said before the shot, Dr. Michael had “absolutely no medical issues” and no underlying conditions. However, authorities later categorized his death as “natural.”
Updated Sept. 12, 2021: A study of Pfizer and Moderna vaccines finds teenage boys are six times more likely to suffer heart issues from Covid-19 vaccination than from Covid. (However, in both instances, the risk is considered slight.)
Frail, elderly
Health officials in Norway sounded the alarm after 23 patients died shortly after receiving the Pfizer Covid-19 vaccine. They advise doctors to use caution in administering the shot to “very frail elderly patients.”
After investigating 13 of the deaths, the Norwegian authorities concluded that common side effects from so-called “RNA” vaccines may be too much for a frail elderly person to handle, and may contribute to their death.
“There is a possibility that these common adverse reactions, that are not dangerous in fitter, younger patients and are not unusual with vaccines, may aggravate underlying disease in the elderly,” said Steinar Madsen, medical director of the Norwegian Medicines Agency.
CDC said it is monitoring the impact of the vaccines on already-frail patients such as the chronically ill in nursing homes.
Several clusters of elderly patients in U.S. nursing homes died after Pfizer or Moderna Covid-19 vaccine. In one group, a number of the patients who died tested positive for Covid-19 after vaccination.
Israel announced that about half of the adults infected with Covid-19 during its outbreak in the June 2021 time period were fully vaccinated. The fully-vaccinated individuals had gotten Pfizer’s shots.
Graves Disease
Studies in Mexico and Turkey link the autoimmune thyroid disorder Graves disease to Covid-19 vaccination in numerous female health care workers, including two who were breastfeeding. Pfizer-BioNTech was the vaccine given in Mexico. A Chinese vaccine was given in Turkey. Read more at the link here.
Novavax
Updated June 18, 2022: The FDA flagged the non-mRNA shot Novavax for heart issues similar to the mRNA vaccines, shortly before recommending the okay for Novavax in the US.
Johnson and Johnson
Updated Oct. 9, 2022: Transplant Rejection: A study by Japanese researchers published in June 2022 in the Journal of Clinical Medicine showed that acute corneal allografts may be rejected by those who have recently received Covid shots. There are other published studies regarding organ transplant rejection after Covid vaccination. Other vaccines, including flu shots, are also believed to cause organ transplant rejection in some, say scientists.
Updated Oct. 1, 2022: A study further confirms Covid-19 vaccination leads to a small and hopefully temporary change in menstrual cycle length.
Updated May 11, 2022: FDA limits use of Johnson & Johnson vaccine citing risk of thrombosis with thrombocytopenia syndrome (TTS): blood clots in combination with low levels of blood platelets.
Update April 26, 2022: Rates of Guillain-Barre “continue to be unusually high after Johnson & Johnson shot” according to a new analysis. “The findings confirm data seen in the Vaccine Adverse Event Reporting System (VAERS) that led to the FDA warning about the Johnson & Johnson vaccine in July 2021….A head-to-head comparison showed the Johnson & Johnson vaccine carried a 20% higher risk for Guillain-Barré than the mRNA shots.”
Updated Jan. 20, 2022: The FDA has added a warning about immune thrombocytopenia, ITP, to Johnson & Johnson’s vaccine.
Update Jan. 20, 2022: European advisers recommended adding warnings about transverse myelitis, a serious spinal inflammation neurological disorder that can paralyze, to Johnson & Johnson’s and AstraZeneca’s Covid-19 vaccines.Updated Jan. 13, 2022: A study finds vaccination impacts and delays women’s periods.
Update Dec. 16, 2021: CDC warns of risk of blood clots, Thrombosis with Thrombocytopenia Syndrome (TTS), with Johnson & Johnson vaccine and recommends people get Moderna or Pfizer, instead.
Update Dec. 15, 2021: A CDC analysis of adverse events reported to the Vaccine Safety Datalink system confirms an increased risk of Guillain-Barre paralysis after Johnson and Johnson Covid-19 vaccination.
Update Nov. 7, 2021: A U.S. study finds after 6 mos. Moderna vaccine effectiveness drops to 60%. Pfizer drops to 49%. J&J drops to 13%. Last yr, FDA’s Dr. Hahn said FDA wouldn’t authorize vaccines that weren’t at least 50% effective.
Update Oct. 2021: A study finds link between Johnson and Johnson Covid-19 vaccine and Guillain-Barre paralysis.
Updated Oct. 6, 2021: Slovenia has temporarily halted Johnson & Johnson after the stroke death of a 20 year old woman.
Updated Oct. 3, 2021: The European Medicines Agency recommended that blood clotting in deep veins and immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as adverse reactions to Johnson and Johnson vaccine.
Update Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.
Menstrual changes after covid-19 vaccination
Update Sept. 9, 2021: An August 10 study in JAMA Cardiology urged caution in giving Johnson and Johnson Covid-19 vaccine to certain high risk patients due to the vaccine link to a serious blood disorder: thrombocytopenia with thrombosis. “One of the devastating manifestations of this syndrome, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST),” say the study authors.
Update July 22, 2021: The European Union added Guillain-Barré syndrome, an autoimmune paralysis disorder, as a possible side effect from Johnson and Johnson’s Covid-19 vaccine.
Update July 12, 2021: The FDA added warnings about Guillain-Barre autoimmune paralysis, in which the immune system attacks the body’s nerves, after Johnson and Johnson vaccine. According to reports, the cases have primarily been reported about two weeks after vaccination, mostly in men, and “any aged 50 and older.”
The Johnson and Johnson Covid-19 vaccine was temporarily removed from the market in the U.S. on April 16, 2021 while health officials studied reports of blood clot injuries.
Updated Aug. 4: A new, independent study of medical records found the incidences of myocarditis and pericarditis are more than five times more common than CDC reported.
The Johnson and Johnson vaccine was allowed back on the market April 27, 2021 with new warnings about the disorder.
Swedish health officials determined that people under age 65 should not get the Johnson and Johnson vaccine due to reports of blood clots.
An editorial in the Journal of the American Medical Association recommended women under age 50 avoid the Johnson and Johnson Covid-19 vaccine due to concerns about blood clots: a blood disorder known as cerebral venous sinus thrombosis (CVST) with thrombocytopenia following the Johnson and Johnson vaccine.
On June 11, the European Union’s drug regulator announced it will not use batches of the Johnson & Johnson COVID-19 vaccine that were made at a Baltimore, Maryland-based plant around the time that cross-contamination manufacturing problems were reported at the facility.
Anonymous sources claimed that up to 60 million doses of the Johnson and Johnson vaccine had to be thrown out. But the FDA issued a news release saying that two batches from the Baltimore plant were safe to use. The FDA said “several other batches are not suitable for use, but additional batches are still under review.”
Denmark banned the Johnson and Johnson vaccine altogether saying “the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine”.
AstraZeneca (not given in the U.S.)
Capillary Leak Syndrome
The European Medicines Agency required Capillary Leak Syndrome to be added to the warning label of AstraZeneca’s Covid-19 vaccine.
Update Jan. 20, 2022: European advisers recommended adding warnings about transverse myelitis, a serious spinal inflammation neurological disorder that can paralyze, to Johnson & Johnson’s and AstraZeneca’s Covid-19 vaccines.
Update Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.
Menstrual changes after covid-19 vaccination
Update: Sept. 9, 2021: An August 10 study in JAMA Cardiology urged caution in giving AstraZeneca Covid-19 vaccine to certain high risk patients due to the vaccine link to a serious blood disorder: thrombocytopenia with thrombosis. “One of the devastating manifestations of this syndrome, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST),” say the study authors.
The AstraZeneca Covid-19 vaccine has been linked to a dangerous disorder involving blood clots with low blood platelets.
On April 7, 2021: The European Medicines Agency says it made the association after it analyzed 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of March 22, 2021, 18 of which were fatal.
In Spain, the AstraZeneca shot has been restricted in people under age 60 due to reports of blood clots in younger people.
Bulgaria, Iceland and Norway halted AstraZeneca shots due to blood issues or impact on frail. Iceland, and perhaps some others, reinstated it in people over age 70 and, perhaps, in some over age 60.
Austria, Italy and Romania banned certain “lots” or batches of the AstraZeneca shots.
Denmark stopped using the AstraZeneca Covid-19 vaccine altogether after investigations into blood clots.
The Italian government recently restricted AstraZeneca Covid-19 vaccine to adults over age 60 after a teenager who got the shot died from a rare form of blood clotting. Eighteen-year-old Camilla Canepa died after getting vaccinated May 25, 2021.
Several other European countries have also stopped giving the AstraZeneca COVID-19 vaccine to people below a certain age, usually ranging from 50 to 65.
Several Brazilian states suspended use of AstraZeneca’s Covid-19 vaccine for pregnant women in May 2021 after a pregnant woman died after getting vaccinated. The decisions follow the recommendation of the country’s National Health Surveillance Agency, which recommended “immediate suspension” of the AstraZeneca Covid-19 vaccine for pregnant women after results of vaccine adverse events monitoring in the country.
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.” In the U.K., scientists flagged “bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine.” A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca’s vaccine. Six were women, all had facial paralysis, “all progressed to quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement.”
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Updated Dec. 14, 2021: A British study study found people at increased risk of heart inflammation from AstraZeneca (not used in U.S.), Pfizer and Moderna Covid-19 vaccines.
Austria: Banned certain “lots” or batches of AstraZeneca shots.
Brazil: Several Brazilian states suspended use of AstraZeneca’s Covid-19 vaccine for pregnant women in May 2021 after a pregnant woman died after getting vaccinated. The decisions follow the recommendation of the country’s National Health Surveillance Agency, which recommended “immediate suspension” of the AstraZeneca Covid-19 vaccine for pregnant women after results of vaccine adverse events monitoring in the country.
Updated Oct. 23, 2021: A study of AstraZeneca vaccine (not used in the U.S.) finds 30% preterm birth rate for pregnant women vs. 0% in the control group. (The study was done in women in Brazil, the UK and S. Africa)
Bulgaria: Bulgaria, Iceland and Norway halted AstraZeneca shots for a time due to blood issues or impact on frail. Iceland, and possibly others, reinstated it in people over age 70 and, perhaps, in some over age 60.
Denmark: Updated Dec. 24, 2021: A Danish study found people at “significantly increased risk” or heart inflammation after Moderna and Pfizer Covid-19 vaccination “primarily driven by an increased risk among individuals aged 12-39 years.”
Stopped using the AstraZeneca Covid-19 vaccine and the Johnson and Johnson vaccine altogether after investigations into blood clots.
Updated Oct. 6, 2021: Sweden and Denmark have halted use of Moderna in people under age 30 due to increased risk of heart injuries such as myocarditis.
European Union: Updated Oct. 28, 2022: The European Medicines agency recommends “heavy menstrual bleeding” be disclosed as side effect of Covid shots Comirnaty and Spikevac.
Updated Aug. 5, 2022: The European Medicines Agency (EMA) recommends Novavax’s Covid-19 vaccine carry warnings about heart inflammation: myocarditis and pericarditis. The FDA flagged heart side effects o Novavax in June of 2022.
Updated Jan. 20, 2022: European advisers recommended adding warnings about transverse myelitis, a serious spinal inflammation neurological disorder that can paralyze, to Johnson & Johnson’s and AstraZeneca’s Covid-19 vaccines.
Updated Nov. 13, 2021: The European Medicines Agency announced a review of Moderna vaccine and a possible link to Capillary Leak Syndrome, “a rare disorder involving repeated leaks of large amounts of plasma from blood vessels into nearby body cavities and muscles. The condition—known as Clarkson’s disease—can result in a sharp drop in blood pressure that can lead to organ failure or even death.”
Earlier in the year, the EMA required Capillary Leak Syndrome to be added to the warning label of AstraZeneca’s Covid-19 vaccine (which is not used in the U.S.)
Oct. 3, 2021: The European Medicines Agency recommended that blood clotting in deep veins and immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as adverse reactions to Johnson and Johnson vaccine. The ITP disorder is also linked to the AstraZeneca Covid-19 vaccines, which aren’t currently used in the US..
July 22, 2021: The European Union added Guillain-Barré syndrome, an autoimmune paralysis disorder, as a possible side effect from Johnson and Johnson’s Covid-19 vaccine.
The AstraZeneca Covid-19 vaccine (not currently approved in the U.S.) has been linked to a dangerous disorder involving blood clots with low blood platelets. On April 7, 2021, the European Medicines Agency says it made the association after it analyzed 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of March 22, 2021, 18 of which were fatal.
On June 11, the European Union’s drug regulator announced it will not use batches of the Johnson & Johnson COVID-19 vaccine that were made at a Baltimore, Maryland-based plant around the time that cross-contamination manufacturing problems were reported at the facility.
Several European countries have stopped giving the AstraZeneca COVID-19 vaccine to people below a certain age, usually ranging from 50 to 65.
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.” In the U.K., scientists flagged “bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine.” A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca’s vaccine. Six were women, all had facial paralysis, “all progressed to quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement.”
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Finland: Updated Oct. 7, 2021: Finland joins Sweden and Denmark in pausing use of Moderna in men 30 and under due to heart issues after a Nordic study found that men under the age of 30 were at a higher risk of developing myocarditis, an inflammation of the heart muscle.
Hong-Kong: Updated Aug. 31, 2022: A Hong Kong study finds Pfizer vaccine carries increased risk of hemorrhragic stroke after Pfizer vaccine. The study authors say it’s still a benefit to get vaccinated, though, because the stroke rate among Covid patients is even higher. But that wrongly assumes vaccination prevents Covid. It also compares the wrong pools of patients. To look at true risk vs. benefit, the stroke rate should be compared between vaccinated people and all unvaccinated people– not just those with Covid.
Updated Aug. 17: An analysis in Hong Kong shows risk of Bell’s palsy is higher with CoronaVac (Sinovac Biotech) shot, a vaccine formulation not currently used in U.S. Bell’s palsy is facial paralysis, muscle twitching, or weakness. It may include change in taste, and pain around the ear, increased sensitivity to sound known as hyperacusis. An adverse event analysis of U.S. reports shows 4,154 Bell’s Palsy after Covid-19 vaccination.
Iceland: Halted AstraZeneca shots due to blood issues in March, then reinstated it for people over age 70 and perhaps some over age 60.
Updated Oct. 10, 2021: Iceland joins Finland, Sweden and Denmark in pausing Moderna due to increased heart issues such as myocarditis and pericarditis. While some of the countries are permitting Moderns in people over age 30, Iceland is not permitting its use at all, currently.
India: Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.” In the U.K., scientists flagged “bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine.” A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca’s vaccine. Six were women, all had facial paralysis, “all progressed to quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement.”
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Israel: Update: June 25, 2022: Nearly every measure finds the Covid infection rate is higher among the vaccinated than among the unvaccinated.
The Israeli Ministry of Health announced it’s monitoring for heart inflammation after Pfizer’s vaccine due to reports of problems.
Announced that about half of the adults infected with Covid-19 during its outbreak in the June 2021 time period were fully vaccinated. The fully-vaccinated individuals had gotten Pfizer’s shots.
Update Aug. 24, 2021: In highly-vaccinated Israel, recognition that vaccination likely does not confer protection beyond a few months, the country has reimagined its vaccine passports. They will only apply to people who have had three shots, and only be good for a six month period of time.
Updated Sept. 9 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from Israel. “Vaccination had a strong association with an increased risk of myocarditis as well as increased risks of lymphadenopathy [swelling or inflammation of lymph nodes], appendicitis, and herpes zoster infection.”
Italy: Restricted AstraZeneca Covid-19 vaccine to adults over age 60 after a teenager who got the shot died from a rare form of blood clotting. Eighteen-year-old Camilla Canepa died after getting vaccinated May 25, 2021.
Banned certain “lots” or batches of the AstraZeneca shots.
Japan: Updated Oct. 9, 2022: A study by Japanese researchers published in June 2022 in the Journal of Clinical Medicine showed that acute corneal allografts may be rejected by those who have recently received Covid shots. There are other published studies regarding organ transplant rejection after Covid vaccination. Other vaccines, including flu shots, are also believed to cause organ transplant rejection in some, say scientists.
Mexico: Studies in Mexico and Turkey link the autoimmune thyroid disorder Graves disease to Covid-19 vaccination in numerous female health care workers, including two who were breastfeeding. Pfizer-BioNTech was the vaccine given in Mexico. A Chinese vaccine was given in Turkey. Read more at the link here.
Norway: Halted AstraZeneca shots. Cautioned use of the vaccine in “very frail elderly patients” after nearly two dozen deaths.
“There is a possibility that these common adverse reactions, that are not dangerous in fitter, younger patients and are not unusual with vaccines, may aggravate underlying disease in the elderly,” said Steinar Madsen, medical director of the Norwegian Medicines Agency.
Romania: Banned certain “lots” or batches of the AstraZeneca shots.
Slovenia: Updated Oct. 6, 2021: Slovenia has temporarily halted Johnson & Johnson after the stroke death of a 20 year old woman.
South Africa: Updated Oct. 23, 2021: A study of AstraZeneca vaccine (not used in the U.S.) finds 30% preterm birth rate for pregnant women vs. 0% in the control group. (Study done in women in S. Africa, UK, and Brazil.)
Spain: The AstraZeneca shot has been restricted in people under age 60 due to reports of blood clots in younger people.
Sweden: Health officials determined that people under age 65 should not get the Johnson and Johnson vaccine due to reports of blood clots.
Updated Oct. 6, 2021: Sweden and Denmark have halted use of Moderna in people under age 30 due to increased risk of heart injuries such as myocarditis.
Taiwan: Updated Nov. 14, 2021: Taiwan’s health minister announced temporary suspension of the second dose of Covid-19 vaccine for children due to concerns about myocarditis heart inflammation. Pfizer is the vaccine given in Taiwan.
Turkey: Studies in Mexico and Turkey link the autoimmune thyroid disorder Graves disease to Covid-19 vaccination in numerous female health care workers, including two who were breastfeeding. Pfizer-BioNTech was the vaccine given in Mexico. A Chinese vaccine was given in Turkey. Read more at the link here.
UK:
Updated Dec. 14, 2021: A British study study found people at increased risk of heart inflammation from AstraZeneca (not used in U.S.), Pfizer and Moderna Covid-19 vaccines.
Update Oct. 30, 2021: A UK study finds “Household Secondary Attack Rate for delta infection, regardless of vaccination status, was 26%” and “peak viral load did not differ by vaccination status.”
Update Oct. 13, 2021: Data from the UK finds vaccines are “highly effective,” but effectiveness wanes after as little as 3-4 months.
Update Oct. 23, 2021: A study of AstraZeneca vaccine (not used in the U.S.) finds 30% preterm birth rate for pregnant women vs. 0% in the control group (among women in S. Africa, Brazil, and UK)
Update Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.
Menstrual changes after covid-19 vaccination
Some scientists analyzed adverse event reports and called upon the Medicines and Healthcare products Regulatory Agency to stop the Covid-19 vaccines as “not safe for human use” due to reports of issues with bleeding/clotting, pain, immune system, neurological, loss of sight/hearing/smell speech, and questions about impact in pregnant women.
Update: Researchers in the United Kingdom are studying two additional cases of Functional Neurological Disorder (FND) in women in their 30s after receiving Covid-19 vaccines.
FND is a neurological disorder involving malfunctioning of the nervous system and how the brain and body transmit signals. Symptoms can include limb weakness, paralysis, tremor, spasms, problems walking, speech problems, tingling, vision loss, seizures, fatigue, anxiety, chronic pain, memory symptoms, and blackouts.
An analysis of Covid-19 vaccine adverse events showed hundreds of thousands of reports of such symptoms.
In January, videos showing vaccine patients suffering such symptoms were treated by media outlets such as Wired as if they were fake news and “dangerous” misinformation.
In fact, the videos garnered the attention of scientists who investigated and concluded they were early warnings of what happens to some who get Covid-19 vaccines.
The newest cases are outlined in the journal Neurology and include:
- A 38-year old woman who got her first dose of Pfizer’s vaccine and quickly developed weakness around her ear, mouth, left arm and leg. She went to the ER the next day and was diagnosed with Bell’s palsy or a transient ischemic attack. Problems continued months later, including memory issues, and she was diagnosed with FND.
- A 36-year-old woman who got her second dose of Moderna and quickly noticed weakness in right hand and right leg limping. A day later she reported severe leg heaviness, fatigue, movement difficulties. After physical therapy her right-side weakness improved but she awoke weeks later with left-side weakness, tightness and heaviness in neck, difficulties with daily living, rapid muscle fatigue, dragging right foot, and tremor. She was diagnosed with FND.
United States: Updated Oct. 8, 2022: Florida surgeon general advises young men should avoid Covid vaccines due to 84% increase in the relative incidence of cardiac-related death among males 18-39within 28 days following mRNA vaccination.
Updated Oct. 1, 2022: A study further confirms Covid-19 vaccination leads to a small and hopefully temporary change in menstrual cycle length.
Updated Sept. 1, 2022: A study in the journal Vaccine finds: Excess risk of serious adverse events from Pfizer and Moderna Covid-19 vaccines outweighs risks from Covid-19 itself. Pfizer vaccine: 36% higher risk of serious adverse events than placebo. Moderna: 6% higher. Combined: 16% higher.
Updated June 18, 2022: The FDA flagged the non-mRNA shot Novavax for heart issues similar to the mRNA vaccines, shortly before recommending the okay for Novavax in the US.
Update June 14, 2022: Pop star Justin Bieber announces he has Ramsay Hunt Syndrome paralysis. Scientists have found a suspected link between herpes/shingles/chickenpox activation or reactivation after Covid-19 vaccine, leading to facial paralysis, hearing loss, tinnitus and other disorders.
Updated May 11, 2022: FDA limits use of Johnson & Johnson vaccine citing risk of thrombosis with thrombocytopenia syndrome (TTS): blood clots in combination with low levels of blood platelets.
Update April 26, 2022: Rates of Guillain-Barre “continue to be unusually high after Johnson & Johnson shot” according to a new analysis. “The findings confirm data seen in the Vaccine Adverse Event Reporting System (VAERS) that led to the FDA warning about the Johnson & Johnson vaccine in July 2021….A head-to-head comparison showed the Johnson & Johnson vaccine carried a 20% higher risk for Guillain-Barré than the mRNA shots.”
Updated March 12: Multiple studies document vaccine-associated tinnitis, or ringing/noise in one or both ears that can be debilitating.
Updated Feb. 14, 2022: A pathology report on two children who died of heart issues after their second Pfizer Covid-19 vaccine implicates the vaccine as the cause.
Updated Jan. 20, 2022: The FDA has added a warning about immune thrombocytopenia, ITP, to Johnson & Johnson’s vaccine.
Update Jan. 13, 2022: A study finds vaccination impacts and delays women’s periods.
Update Dec. 16, 2021: CDC warns of risk of blood clots, Thrombosis with Thrombocytopenia Syndrome (TTS), with Johnson & Johnson vaccine and recommends people get Moderna or Pfizer, instead.
Update Dec. 15, 2021: A CDC analysis of adverse events reported to the Vaccine Safety Datalink system confirms an increased risk of Guillain-Barre paralysis after Johnson and Johnson Covid-19 vaccination.
Update Oct. 2021: A study finds link between Johnson and Johnson Covid-19 vaccine and Guillain-Barre paralysis.
Update Oct. 2021: A study finds link between Johnson and Johnson Covid-19 vaccine and Guillain-Barre paralysis.
Update Nov. 21, 2021: An analysis presented at the American Heart Association and published in the journal Cardiology warns of a “dramatic” increase in heart risk for most people who got Covid-19 RNA vaccine.
Update Nov. 7, 2021: A U.S. study finds after 6 mos. Moderna vaccine effectiveness drops to 60%. Pfizer drops to 49%. J&J drops to 13%. Last yr, FDA’s Dr. Hahn said FDA wouldn’t authorize vaccines that weren’t at least 50% effective.
Update Oct. 4, 2021: A study by university and NIH scientists in the U.S. finds Pfizer vaccine antibodies disappear after about 7 months in many patients.
Update Sept. 12, 2021: A study of Pfizer and Moderna vaccines finds teenage boys are six times more likely to suffer heart issues from Covid-19 vaccination than from Covid. (However, in both instances, the risk is considered slight.)
Update Sept. 9, 2021: An August 10 study in JAMA Cardiology confirms the previously identified Pfizer vaccine’s myocarditis (heart inflammation) risk in young boys.
Update Sept. 4, 2021: Acute CNS Demyelination and Multiple Sclerosis: A new study in Journal of Neurology examines possible links between Pfizer and Moderna vaccines, and acute Central Nervous System (CNS) demyelination, including Multiple Sclerosis (MS).
Demyelinating diseases damage the protective covering surrounding nerve fibers in the brain, optic nerves and spinal cord, causing neurological problems. In the study, four patients had the Pfizer vaccine and three had the Moderna vaccine. Within 21 days of the first or second dose, the patients developed active CNS demyelination of the optic nerve, brain, and/or spinal cord leading to “visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance, and limb weakness.”
Age ranged from 24 to 64 years old. Four patients were ultimately diagnoses with exacerbation of their stable MS.
Two were diagnosed with new cases of MS.
One was diagnosed with neuromyelitis optica.
Update Aug. 24, 2021: With evidence of seriously-waning immunity at the five- to six-month mark, CDC is now recommending a third “booster” shot. In highly-vaccinated Israel, recognition that vaccination likely does not confer protection beyond a few months, the country has reimagined its vaccine passports. They will only apply to people who have had three shots, and only be good for a six month period of time.
Update Aug. 16, 2021: Antibody Dependent Enhancement (ADE) (read more here). According to studies:
- Antibody Dependent Enhancement (ADE) can make vaccinated people more susceptible to serious infection from the virus
- “ADE may be a concern” for those who have been vaccinated for Covid-19
- With ADE, after people get vaccinated for an initial virus, infection by a subsequent variant or strain of the virus can result in “increased viral replication and more severe disease, leading to major safety risks”
- ADE can also “occur when neutralizing antibodies (which bind the virus and stop it from causing infection) are present at low enough levels that they don’t protect against infection. Instead, they can form immune complexes with viral particles, which in turn leads to worse illness”
- This concern was initially described by some scientists who were subsequently banned from media platforms that incorrectly claimed the scientists were disseminating disinformation
Update Aug. 4, 2021: A new, independent study of medical records found the incidences of myocarditis and pericarditis are more than five times more common than CDC reported.
Update July 12, 2021: The FDA added warnings about Guillain-Barre autoimmune paralysis, in which the immune system attacks the body’s nerves, after Johnson and Johnson vaccine. According to reports, the cases have primarily been reported about two weeks after vaccination, mostly in men, and “any aged 50 and older.”
In late June, the first case of a blood clot disorder called “thrombosis with thrombocytopenia” after an RNA double-dose vaccine was been reported in the Annals of Internal Medicine. The case was that of a 65-year-old man who developed symptoms ten days after his second dose of the Moderna vaccine. Because the blood clot disorder was not previously warned about in the Moderna and Pfizer vaccines, doctors treated the patient with heparin, the very drug that’s not supposed to be used in post-vaccine patients suffering from the disorder because it could actually worsen the condition.
Dr. Peter McCullough, cardiologist and Vice Chief of Medicine at Baylor University Medical Center in Dallas, Texas, has called for a halt to vaccinating 30-year olds due to “no clinical benefit” and safety concerns.
A petition of scientists led by Linda Wastila, Professor, Pharmaceutical Health Services Research University of Maryland School of Pharmacy is calling for Covid-19 vaccines to be disapproved.
The Food and Drug Administration has added a new warning to Pfizer and Moderna Covid-19 vaccines about risk of heart inflammation.
As of June of 2021, CDC said that more than 1,200 cases of heart inflammation (myocarditis of pericarditis) in young people had been reported after Pfizer and Moderna Covid-19 vaccination.
- More than half were after the second dose.
- Most of the injuries are in males under age 30.
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines [Pfizer-BioNTech, Moderna] in a number of patients are described in a scientific article:
- Two patients with clinically suspected myocarditis
- One patient with stress cardiomyopathy
- Two patients with pericarditis
According to the research:
- The two patients with clinically suspected myocarditis were otherwise healthy young men who presented with acute substernal chest pressure and/or dyspnea after receiving the second dose of the vaccine and were found to have diffuse ST elevations on electrocardiogram (ECG), elevated cardiac biomarkers and inflammatory markers, and mildly reduced left ventricular (LV) function on echocardiography. Both patients met the modified Lake Louise Criteria for acute myocarditis by cardiac magnetic resonance imaging.
- A case of stress cardiomyopathy occurred in a 60-year-old woman with known coronary artery disease (CAD) and previously normal LV function, who presented with new exertional symptoms, ECG changes, and apical akinesis following the second dose of the vaccine.
- The two patients with pericarditis who presented with chest pain, elevated inflammatory markers, and pericardial effusions after receiving the vaccine.
The Johnson and Johnson Covid-19 vaccine was temporarily removed from the market in the U.S. on April 16, 2021 while health officials studied reports of blood clot injuries. Among them was an 18-year old teen named Emma Burkey, who got sick about a week after the Johnson and Johnson Covid-19 vaccine and ended up having three brain surgeries related to blood clots and seizures.
The Johnson and Johnson vaccine was allowed back on the market April 27, 2021 with new warnings about the disorder.
An editorial published in the Journal of the American Medical Association recommended women under age 50 avoid the Johnson and Johnson Covid-19 vaccine due to concerns about blood clots. The recommendation discussed 12 case reports of a blood disorder known as cerebral venous sinus thrombosis (CVST) with thrombocytopenia following the Johnson and Johnson vaccine.
An otherwise healthy South Florida doctor, Gregory Michael, died of a brain hemorrhage 16 days after he got Pfizer’s Covid-19 vaccine. Authorities concluded he died of a blood disorder called “immune thrombocytopenia” (ITP) that can prevent blood from clotting and cause internal bleeding. His wife said a blood test showed the level of his platelets to be at “zero.” She said before the shot, Dr. Michael had “absolutely no medical issues” and no underlying conditions. However, authorities later categorized his death as “natural.”
Several clusters of elderly patients in U.S. nursing homes died after Pfizer or Moderna Covid-19 vaccine. In one group, a number of the patients who died tested positive for Covid-19 after vaccination.
CDC falsely claimed that studies showed Covid-19 vaccines are effective for those who already had Covid-19. In fact, studies showed the opposite.
Anonymous sources claimed that up to 60 million doses of the Johnson and Johnson vaccine had to be thrown out. But the FDA issued a news release saying that two batches from the Baltimore plant were safe to use. The FDA said “several other batches are not suitable for use, but additional batches are still under review.”
According to Epoch Times, in June 2021 nearly 4,000 fully vaccinated people in Massachusetts tested positive for Covid-19. On April 30, “the CDC reported that some 10,626 breakthrough cases were reported in 46 states and territories.” Breakthrough cases are where fully vaccinated people still end up infected with Covid-19.
Scientists hoped that Covid-19 vaccines would be effective in variants of Covid-19, which are mutations that occur naturally with viruses and were always expected with Covid-19. However, the vaccine effectiveness against variants may be limited. CDC and vaccine makers are studying the medical landscape to find out more.
Other states, such as Maine, are noting Covid-19 deaths occurring in fully vaccinated people.
Update Oct. 8, 2021: A study of health care workers in Vietnam found vaccinated people infected with Delta Covid-19 carry “unusually high viral loads” in their nostrils that are “251 times higher.” The study said that during a period when the vaccinated patients are infected but don’t yet know it, they could be responsible for heightened spread to other vaccinated or the unvaccinated. The subjects had been fully vaccinated with AstraZeneca’s vaccine, which is not used in the U.S.
Nearly every measure finds the Covid infection rate is higher among the vaccinated than among the unvaccinated.
A case study finds suspected link between Ramsay Hunt syndrome and Covid-19 vaccine.
A published pathology report on two children who died of heart issues after their second Pfizer Covid-19 vaccine implicates the vaccine as the cause.
A study finds vaccination impacts and delays women’s periods.
A CDC analysis finds increased risk of Guillain Barre paralysis after Covid vaccination, Dec. 2021
An analysis presented at the American Heart Association and published in the journal Cardiology warns of a “dramatic” increase in heart risk for most people who got Covid-19 RNA vaccine.
US study finds dramatically waned immunity for all 3 vaccines after 6 months: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
UK study finds no difference in peak viral load between vaccinated and unvaccinated, Oct. 28, 2021: https://www.thelancet.com/action/showPdf?pii=S1473-3099%2821%2900648-4
Israeli data confirms Pfizer vacine immunity wears off after just a few months in all age groups, Oct. 27, 2021: Waning Immunity after the BNT162b2 Vaccine in Israel
Durability of immune responses to the BNT162b2 mRNA vaccine, Sept. 30, 2021: https://www.biorxiv.org/content/10.1101/2021.09.30.462488v1.article-info
Additional case studies of myocarditis in people after Pfizer and Moderna Covid-19 vaccines, Aug. 18, 2021. Available from: https://www.nejm.org/doi/full/10.1056/NEJMc2109975
Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam, Aug. 10, 2021. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733
Zuckerman DM. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health. Am J Public Health [Internet]. 2021 Jun;111(6):1065–9. Available from: http://dx.doi.org/10.2105/AJPH.2021.306273
Food and Drug Administration. Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry [Internet]. 2020 [cited 2020 Oct 6]. Available from: https://www.fda.gov/media/139638/download
Food and Drug Administration. FDA Briefing Document. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19 [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.fda.gov/media/146217/download
CDC. Risk for COVID-19 infection, hospitalization, and death by age group [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid- data/investigations-discovery/hospitalization-death-by-age.html
CDC. COVID-19 Pandemic Planning Scenarios [Internet]. 2021 [cited 2021 May 28]. Available from:
https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html
CDC. Estimated disease burden of COVID-19 [Internet]. 2021 [cited 2021 May 28]. Available from:
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html
Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science [Internet]. 2021 Feb 5;371(6529). Available from: http://dx.doi.org/10.1126/science.abf4063
Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature [Internet]. 2021 May 24; Available from: http://dx.doi.org/10.1038/s41586-021-03647-4
Breton G, Mendoza P, Hagglof T, Oliveira TY, Schaefer-Babajew D, Gaebler C, et al. Persistent Cellular Immunity to SARS-CoV-2 Infection. bioRxiv [Internet]. 2020 Dec 9; Available from: http://dx.doi.org/10.1101/2020.12.08.416636
Hall VJ, Foulkes S, Charlett A, Atti A, Monk EJM, Simmons R, et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet [Internet]. 2021 Apr 17;397(10283):1459–69. Available from: http://dx.doi.org/10.1016/S0140-6736(21)00675-9
Krammer F, Srivastava K, Simon V, the PARIS team. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine [Internet]. bioRxiv. medRxiv; 2021. Available from: http://medrxiv.org/lookup/doi/10.1101/2021.01.29.21250653
Samanovic MI, Cornelius AR, Wilson JP, Karmacharya T, Gray-Gaillard SL, Allen JR, et al. Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals. medRxiv [Internet]. 2021 Feb 9; Available from: http://dx.doi.org/10.1101/2021.02.07.21251311
Camara C, Lozano-Ojalvo D, Lopez-Granados E, Paz-Artal E, Pion M, Correa-Rocha R, et al. Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals [Internet]. bioRxiv. 2021 [cited 2021 May 28]. p. 2021.03.22.436441. Available from: https://www.biorxiv.org/content/10.1101/2021.03.22.436441v1
Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. A cautionary note on recall vaccination in ex-COVID-19 subjects [Internet]. bioRxiv. medRxiv; 2021. Available from: http://medrxiv.org/lookup/doi/10.1101/2021.02.01.21250923
Ogata AF, Cheng C-A, Desjardins M, Senussi Y, Sherman AC, Powell M, et al. Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clin Infect Dis [Internet]. 2021 May 20; Available from: http://dx.doi.org/10.1093/cid/ciab465
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med [Internet]. 2005 Aug;11(8):875–9. Available from: http://dx.doi.org/10.1038/nm1267
Chen I-Y, Chang SC, Wu H-Y, Yu T-C, Wei W-C, Lin S, et al. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol [Internet]. 2010 Aug;84(15):7703–12. Available from: http://dx.doi.org/10.1128/JVI.02560-09
Patra T, Meyer K, Geerling L, Isbell TS, Hoft DF, Brien J, et al. SARS-CoV-2 spike protein promotes IL- 6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog [Internet]. 2020 Dec;16(12):e1009128. Available from: http://dx.doi.org/10.1371/journal.ppat.1009128
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol [Internet]. 2020 Sep 4;13(1):120. Available from: http://dx.doi.org/10.1186/s13045-020-00954-7
Suresh SJ, Suzuki YJ. SARS-CoV-2 Spike Protein and Lung Vascular Cells. Journal of Respiration [Internet]. 2020 Dec 31 [cited 2021 May 25];1(1):40–8. Available from: https://www.mdpi.com/2673-527X/1/1/4
Angeli F, Spanevello A, Reboldi G, Visca D, Verdecchia P. SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med [Internet]. 2021 Apr 30; Available from: http://dx.doi.org/10.1016/j.ejim.2021.04.019
Han M, Pandey D. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial Plasminogen Activator Inhibitor-1. Am J Respir Cell Mol Biol [Internet]. 2021 May 18; Available from: http://dx.doi.org/10.1165/rcmb.2020-0544OC
Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci [Internet]. 2021 Mar;24(3):368– 78. Available from: http://dx.doi.org/10.1038/s41593-020-00771-8
Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem Biophys Res Commun [Internet]. 2021 May 21;554:94–8. Available from: http://dx.doi.org/10.1016/j.bbrc.2021.03.100
Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circ Res [Internet]. 2021 Apr 30;128(9):1323–6. Available from: http://dx.doi.org/10.1161/CIRCRESAHA.121.318902
Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient- derived tissues. Proc Natl Acad Sci U S A [Internet]. 2021 May 25;118(21). Available from: http://dx.doi.org/10.1073/pnas.2105968118
Suzuki YJ, Nikolaienko SI, Dibrova VA, Dibrova YV, Vasylyk VM, Novikov MY, et al. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascul Pharmacol [Internet]. 2021 Apr;137:106823. Available from: http://dx.doi.org/10.1016/j.vph.2020.106823
Suzuki YJ, Gychka SG. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines (Basel) [Internet]. 2021 Jan 11;9(1). Available from: http://dx.doi.org/10.3390/vaccines9010036
Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, et al. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin Chem [Internet]. 2020 Sep 8; Available from: http://dx.doi.org/10.1093/clinchem/hvaa213
Kloc M, Uosef A, Kubiak JZ, Ghobrial RM. Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination. Biology [Internet]. 2021 Mar 19;10(3). Available from: http://dx.doi.org/10.3390/biology10030238
Khan I, Hatiboglu MA. Can COVID-19 induce glioma tumorogenesis through binding cell receptors? Med Hypotheses [Internet]. 2020 Nov;144:110009. Available from: http://dx.doi.org/10.1016/j.mehy.2020.110009
Singh N, Bharara Singh A. S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study. Transl Oncol [Internet]. 2020 Oct;13(10):100814. Available from: http://dx.doi.org/10.1016/j.tranon.2020.100814
Madla CM, Gavins FKH, Merchant H, Orlu M, Murdan S, Basit AW. Let’s Talk About Sex: Differences in Drug Therapy in Males and Females. Adv Drug Deliv Rev [Internet]. 2021 May 17; Available from: http://dx.doi.org/10.1016/j.addr.2021.05.014
European Medicines Agency. Assessment Report. Comirnaty (COVID-19 mRNA vaccine (nucleoside- modified)), EMA/707383/2020 Corr.1 [Internet]. 2021 Feb [cited 2021 Apr 13]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public- assessment-report_en.pdf#page=45
European Medicines Agency. Assessment Report. COVID-19 Vaccine Moderna (COVID-19 mRNA Vaccine (nucleoside-modified)), EMA/15689/2021 Corr.1 [Internet]. 2021 Mar [cited 2021 Apr 13]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine- moderna-epar-public-assessment-report_en.pdf#page=47
European Medicines Agency. Assessment Report. COVID-19 Vaccine Janssen, EMA/158424/2021 [Internet]. 2021 Mar [cited 2021 Apr 13]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine-janssen-epar- public-assessment-report_en.pdf#page=50
Pfizer. SARS-CoV- 2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Yakubutsu dōtai shiken no gaiyō bun [summary of pharmacokinetic studies] [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.pmda.go.jp/drugs/2021/P20210212001/672212000_30300AMX00231_I100_1.pdf#pa ge=16
CDC. Selected adverse events reported after COVID-19 vaccination [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse- events.html
Doshi P. FDA response to BMJ on reports of death after covid-19 vaccination [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.bmj.com/content/372/bmj.n149/rr-25
Wyller TB, Kittang BR, Ranhoff AH, Harg P, Myrstad M. Nursing home deaths after COVID-19 vaccination. Tidsskr Nor Laegeforen [Internet]. 2021 May 20;141. Available from: http://dx.doi.org/10.4045/tidsskr.21.0383
Torjesen I. Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds. BMJ [Internet]. 2021 May 27 [cited 2021 May 28];373. Available from: https://www.bmj.com/content/373/bmj.n1372
Food and Drug Administration. Coronavirus (COVID-19) update: FDA Issues Policies to guide medical product developers addressing virus variants [Internet]. 2021 [cited 2021 May 28]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19- update-fda-issues-policies-guide-medical-product-developers-addressing-virus
Owens C. Vaccine boosters could be necessary as soon as September [Internet]. Axios. 2021 [cited 2021 May 28]. Available from: https://www.axios.com/coronavirus-vaccines-boosters-pfizer- moderna-e8d6bed6-8238-4e52-9959-ca4c6a6e0d5a.html
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med [Internet]. 2020 Dec 31;383(27):2603–15. Available from: http://dx.doi.org/10.1056/NEJMoa2034577
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA- 1273 SARS-CoV-2 Vaccine. N Engl J Med [Internet]. 2021 Feb 4;384(5):403–16. Available from: http://dx.doi.org/10.1056/NEJMoa2035389
Thacker PD. Covid-19: How independent were the US and British vaccine advisory committees? BMJ [Internet]. 2021 May 26;373:n1283. Available from: http://dx.doi.org/10.1136/bmj.n1283
Moderna. SARS-CoV- 2 mRNA Vaccine (Moderna) 2.6.4 Yakubutsu dōtai shiken no gaiyō bun [summary of pharmacokinetic studies] [Internet]. 2021 [cited 2021 May 29]. Available from: https://www.pmda.go.jp/drugs/2021/P20210519003/400256000_30300AMX00266_I100_1.pdf#pa ge=7
Thanks to the thousands who have already supported!
